Dr Reddy's unveils osteoporosis drug
Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating...
Hyderabad: Dr Reddy's Labs said it had launched generic Zoledronic Acid injection used for treating osteoporosis and Paget's disease of bone in the US market. Osteoporosis is a disease of bones that leads to an increased risk of fracture while Paget's disease of bone is a chronic disorder that can result in enlarged and misshapen bones.
The company has launched Zoledronic Acid injection (5 mg/ 100 mL) on Wednesday following approval of its abbreviated new drug application (ANDA) by the US Food & Drug Administration (USFDA), the company said in a release.
The injection is generic version of Novartis AG's Reclast injection in the same strength, it added. The Reclast brand had total US sales of approximately $355 million for the most recent twelve months ending February, 2013 according to IMS Health.